SCHEMBL29613411

SCHEMBL29613411

CC(C)(C)OC(=O)c1ccc(Nc2cc(C(=O)N3CCC(N4CCCC4)CC3)ccc2C(=O)N2CCC(N3CCCC3)CC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 18/20 0.71
L3MBTL1 Q9Y468 16/20 0.71
MBTD1 Q05BQ5 9/20 0.71
TP53BP1 Q12888 4/20 0.71
L3MBTL4 Q8NA19 2/20 0.71
CHRM2 P08172 1/20 0.71
CHRM4 P08173 1/20 0.71
CHRM5 P08912 1/20 0.71
CHRM1 P11229 1/20 0.71
ADRA2C P18825 1/20 0.71
CHRM3 P20309 1/20 0.71
OPRK1 P41145 1/20 0.71
PHF20 Q9BVI0 1/20 0.71
MORF4L1 Q9UBU8 1/20 0.71
SPIN1 Q9Y657 1/20 0.54
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510649 1.00 L3MBTL3 (0.71) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL27223881 0.84 L3MBTL3 (0.85) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL29613516 0.84 L3MBTL3 (0.85) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL19730381 0.83 L3MBTL3 (1.00) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL24510772 0.83 L3MBTL3 (0.75) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL24510615 0.80 L3MBTL3 (0.71) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL29613449 0.71 L3MBTL3 (1.00) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL27223857 0.71 L3MBTL3 (1.00) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL29664786 0.71 SPIN1 (0.76) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL30797925 0.70 SPIN1 (1.00) L3MBTL3L3MBTL1MBTD1TP53BP1L3MBTL4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4259133-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2023-10-18 EP disclosed
WO-2022126000-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2022-06-16 WO disclosed